Highly Sensitive Single Domain Antibody–Quantum Dot Conjugates for Detection of HER2 Biomarker in Lung and Breast Cancer Cells

Citations Over TimeTop 10% of 2014 papers

Abstract

Despite the widespread availability of immunohistochemical and other methodologies for screening and early detection of lung and breast cancer biomarkers, diagnosis of the early stage of cancers can be difficult and prone to error. The identification and validation of early biomarkers specific to lung and breast cancers, which would permit the development of more sensitive methods for detection of early disease onset, is urgently needed. In this paper, ultra-small and bright nanoprobes based on quantum dots (QDs) conjugated to single domain anti-HER2 (human epidermal growth factor receptor 2) antibodies (sdAbs) were applied for immunolabeling of breast and lung cancer cell lines, and their performance was compared to that of anti-HER2 monoclonal antibodies conjugated to conventional organic dyes Alexa Fluor 488 and Alexa Fluor 568. The sdAbs-QD conjugates achieved superior staining in a panel of lung cancer cell lines with differential HER2 expression. This shows their outstanding potential for the development of more sensitive assays for early detection of cancer biomarkers.

Related Papers

• → Quantitative Assessment of Antibody Internalization with Novel Monoclonal Antibodies against Alexa Fluorophores(2015)40 cited
• → 2D and 3D immunogold localization on (epoxy) ultrathin sections with and without osmium tetroxide(2020)13 cited
• → Doublecortin immunolabeling in canine gliomas with distinct degrees of tumor infiltration(2022)3 cited
• → Postembedding Immunolabeling of Thin Sections of Drosophila Tissues for Transmission Electron Microscopy(2012)2 cited
• → Specimen Preparation for Immunocytochemistry(2001)